FDA’s process validation on drugs and biologics

Product Format: Live Audio Conference
Presenter(s): Dr. Mukesh Kumar
Conference Date: Wed, Nov 13, 2013
Aired Time: 1 pm ET | 12 pm CT | 11 am MT | 10 am PT
Length: 90 Minute
Price: $227

The most common type of CMC deficiency that is indentified by FDA reviewers is kind of an inadequate process validation. A manufacturer will need to establish the objective evidence that a process will consistently produce a result or product, for the meeting with its predetermined specifications.

Join expert Dr. Mukesh Kumar in this information packed 60-minute conference “FDA's Guidance on Process Validation for Drugs and Biologics- 3 steps to Compliance” on Wednesday, November 13, 2013, to evaluate critical and non-critical process parameters.

For more information:- http://bit.ly/1fld3mt

Special Offer: Use code EVENT10% to get 10% discount.

For any queries feel free to contact Adam K at 1-866-458-2965 or e-mail Adam at [email protected].